Literature DB >> 15089052

Biopharmaceutics classification by high throughput solubility assay and PAMPA.

Kouki Obata1, Kiyohiko Sugano, Minoru Machida, Yoshinori Aso.   

Abstract

The purpose of the present study was to examine the relevancy of the high throughput solubility assay and permeability assay to the biopharmaceutics classification system (BCS). Solubility and permeability were measured by high throughput solubility assay (HTSA) and parallel artificial membrane permeation assay (PAMPA), respectively. High throughput solubility assay was performed using simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid without bile acid (SIF, pH 6.8). We categorize 18 drugs based on the BCS using HTSA and PAMPA. Fourteen out of 18 drugs were correctly classified (78% success rate). The result of the present study showed that HTSA could predict BCS class with a high success rate, and PAMPA could also be useful to predict the permeation of drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15089052     DOI: 10.1081/ddc-120028713

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.

Authors:  Jong Yeon Hwang; Leggy A Arnold; Fangyi Zhu; Aaron Kosinski; Thomas J Mangano; Vincent Setola; Bryan L Roth; R Kiplin Guy
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

2.  Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development.

Authors:  Nicole Wyttenbach; Jochem Alsenz; Olaf Grassmann
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.